NATIONAL CANCER CENTER

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
 
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 38217
 
 
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 3392
 
 
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 28178
 
 
 
A61B DIAGNOSIS; SURGERY; IDENTIFICATION 25215
 
 
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 23144
 
 
 
C07K PEPTIDES 18118
 
 
 
A61M DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY 6148
 
 
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 693
 
 
 
A61N ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY 5102
 
 
 
C07D HETEROCYCLIC COMPOUNDS 5157

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2018/0057,793 METHODS FOR ISOLATING AND PROLIFERATING AUTOLOGOUS CANCER ANTIGEN-SPECIFIC CD8+ T CELLSAug 30, 17Mar 01, 18[C12N]
2018/0059,114 MAGNETIC NANOSTRUCTURE FOR DETECTING AND ISOLATING CIRCULATING TUMOR CELLS COMPRISING ANTIBODY- AND MAGNETIC NANOPARTICLE-CONJUGATED CONDUCTIVE POLYMERAug 25, 16Mar 01, 18[C12Q, G01N]
2018/0031,574 METHOD AND KIT FOR THE DETECTION OF PANCREATIC DYSFUNCTIONMar 01, 16Feb 01, 18[G01N, C07K]
2018/0015,056 PHARMACEUTICAL COMPOSITION FOR INHIBITING GROWTH OF CANCER STEM CELLS, CONTAINING ALDEHYDE INHIBITOR AND BIGUANIDE-BASED COMPOUNDFeb 02, 16Jan 18, 18[A61K]
2018/0015,079 THERAPEUTIC AGENT FOR BILE DUCT CANCERMar 23, 16Jan 18, 18[A61K]
2017/0273,654 X-RAY CT APPARATUSMar 27, 17Sep 28, 17[A61B]
2017/0211,147 METHOD OF PREDICTING REACTION TO SORAFENIB TREATMENT USING GENE POLYMORPHISMMar 23, 15Jul 27, 17[C12Q]
2017/0130,273 ESOPHAGEAL CANCER DETECTION KIT OR DEVICE, AND DETECTION METHODJun 18, 15May 11, 17[C12Q]
2017/0130,278 LUNG CANCER DETECTION KIT OR DEVICE, AND DETECTION METHODJun 18, 15May 11, 17[C12Q]
2017/0121,779 PROSTATE CANCER DETECTION KIT OR DEVICE, AND DETECTION METHODJun 12, 15May 04, 17[C12Q]

View all Publication..

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9920133 Anti-tissue factor monoclonal antibodyFeb 03, 15Mar 20, 18[A61K, C07K]
9907852 Anticancer agent and side-effect-alleviating agentApr 10, 15Mar 06, 18[A61K, C07K]
9902064 Apparatus for controlling stiffness of output link in moving mechanismJan 24, 17Feb 27, 18[B25J]
9880078 Composition for aggregating biological sampleDec 12, 12Jan 30, 18[G01N]
9795586 HNF4-α antagonist and use thereofMar 20, 17Oct 24, 17[A61K]
9790492 Agent for treating cancerAug 19, 13Oct 17, 17[A61K, C07H, C12Q, C12N, G01N]
9708378 Peptides derived from NCAPG2 and their useOct 05, 16Jul 18, 17[A61K, C12N, G01N, C07K]
9700023 Rat embryonic stem cellDec 18, 13Jul 11, 17[A61K, C12N, A01K, G01N]
9700572 Anti-cancer agentSep 24, 14Jul 11, 17[A61K]
9688740 Mutant CTLA4 gene transfected T cell and composition including same for anticancer immunotherapyOct 26, 12Jun 27, 17[A01N, C07K]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2016/0319,253 NOVEL FUSION GENES AS FACTORS RESPONSIBLE FOR GASTRIC CANCERAbandonedDec 18, 14Nov 03, 16[C12Q, C12N, C07K]
2016/0193,238 HNF4-alpha ANTAGONIST AND USE THEREOFAbandonedJan 05, 16Jul 07, 16[A61K]
2016/0130,663 METHOD FOR PREDICTING RESPONSE TO CANCER TREATMENTAbandonedJul 11, 14May 12, 16[C12Q, C12N, G01N]
2016/0084,798 ANALYSIS METHODAbandonedJan 31, 14Mar 24, 16[G01N]
2016/0022,812 THERAPEUTIC AGENTS FOR PANCREATIC CANCERAbandonedOct 08, 15Jan 28, 16[A61K]
2016/0009,799 PHARMACEUTICAL COMPOSITION FOR TREATING CANCERAbandonedMar 06, 13Jan 14, 16[C12N, C07K]
2015/0259,646 Methods for Isolating and Proliferating Autologous Cancer AntiGen-Specific CD8+ T CellsAbandonedMar 12, 15Sep 17, 15[C12N]
2015/0213,639 IMAGE GENERATION APPARATUS AND PROGRAMAbandonedSep 04, 13Jul 30, 15[G06T]
2015/0197,548 Peptides derived from NCAPG2 and their useAbandonedJul 24, 14Jul 16, 15[G01N, C07K]
2015/0191,791 FGFR2 FUSION GENEAbandonedJul 05, 13Jul 09, 15[C12Q, C12N, G01N, C07K]
2015/0184,248 METHOD FOR DETECTING PANCREATIC CANCER AND DETECTION KITAbandonedJun 26, 13Jul 02, 15[C12Q]
2015/0177,246 FUSION GENE OF CEP55 GENE AND RET GENEAbandonedJul 23, 13Jun 25, 15[C12Q, C12N, G01N, C07K]
2015/0057,335 NOVEL FUSION GENES IDENTIFIED IN LUNG CANCERAbandonedAug 20, 14Feb 26, 15[A61K, C12Q, C12N, G01N, C07K]
2014/0186,260 RADIOPHARMACEUTICAL AND PHARMACEUTICAL KITAbandonedDec 24, 13Jul 03, 14[A61K]
2014/0186,261 ANTI-TUMOR AGENT AND ANTI-TUMOR KITAbandonedDec 24, 13Jul 03, 14[A61K]
2014/0080,132 METHOD AND KIT FOR PREDICTING CYTOTOXICITYAbandonedSep 16, 13Mar 20, 14[C12Q]
2013/0236,891 METHOD AND COMPOSITION FOR THE TREATMENT, PREVENTION, AND DIAGNOSIS OF CANCER CONTAINING OR DERIVED FROM CANCER STEM CELLSAbandonedJan 24, 11Sep 12, 13[C12Q, C12N]
2013/0230,869 ANTIBODY AGAINST COLORECTAL CANCER MARKERAbandonedSep 01, 11Sep 05, 13[G01N, C07K]
2013/0198,876 INDUCED MALIGNANT STEM CELLS OR PRE-INDUCTION CANCER STEM CELLS CAPABLE OF SELFREPLICATION OUTSIDE OF AN ORGANISM, PRODUCTION METHOD FOR SAME, AND PRACTICAL APPLICATION FOR SAMEAbandonedMay 25, 11Aug 01, 13[A61K, C12N, G01N]
2013/0149,302 THERAPEUTIC AGENTS FOR PANCREATIC CANCERAbandonedMay 27, 11Jun 13, 13[A61K]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.